Clinical Trial Update: Phase 2 Trial for Chemo-Resistant Gestational Trophoblastic Neoplasias With Pembrolizumab (CR-GTP) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing pembrolizumab for chemo-resistant gestational trophoblastic neoplasia is in progress with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Trophoblastic Neoplasia

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: CHA University | Conditions: Gestational Trophoblastic Neoplasia | Phase 2 | Status: UNKNOWN